Iglim MV 2 mg/500 mg/0.2 mg Tablet
Marketer
Emenox Healthcare
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Iglim MV 2 mg/500 mg/0.2 mg Tablet
Diabetace-Comb 2/500/0.2 mg tablets are classified as antidiabetic medications, a combination therapy for adult type 2 diabetes. This medication assists in regulating blood glucose. Diabetace-Comb should be administered with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with well-controlled blood sugar, as discontinuation without medical consultation risks elevated glucose levels and potential complications such as kidney impairment, vision loss, neuropathy, and limb loss. Remember, this is part of a comprehensive diabetes management plan, including diet, exercise, and weight management as directed by your doctor. Lifestyle choices are integral to diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available fast-acting glucose (e.g., sugary foods, fruit juice) are essential preventative measures. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals require medical consultation. Regular blood glucose monitoring, along with potential blood tests to assess blood cell counts and liver function, are recommended.
Uses of Iglim MV 2 mg/500 mg/0.2 mg Tablet
Managing type 2 diabetes
Major Benefits of Iglim MV 2 mg/500 mg/0.2 mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Swallow the tablet whole; avoid chewing, crushing, or breaking it. The Iglim MV 2 mg/500 mg/0.2 mg Tablet should be administered on an empty stomach.
Common Side effects of Iglim MV 2 mg/500 mg/0.2 mg Tablet:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Iglim MV 2 mg/500 mg/0.2 mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Swallow the tablet whole; avoid chewing, crushing, or fracturing it. Ingest the Iglim MV 2 mg/500 mg/0.2 mg tablet on an empty stomach.
How Iglim MV 2 mg/500 mg/0.2 mg Tablet works:
Each Iglim MV tablet (2 mg/500 mg/0.2 mg) contains a triple-action blend of antidiabetic agents.
SAFETY ADVICE
AlcoholUNSAFE
Alcohol consumption alongside Iglim MV 2 mg/500 mg/0.2 mg tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Iglim MV 2 mg/500 mg/0.2 mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before using this drug.
Breast feedingCONSULT YOUR DOCTOR
The use of Iglim MV 2 mg/500 mg/0.2 mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Iglim MV 2 mg/500 mg/0.2 mg tablets is likely unsafe for individuals with kidney impairment and should be omitted. Medical advice is recommended. Moreover, this medication is contraindicated in patients exhibiting severe kidney dysfunction.
LiverCAUTION
Patients with liver impairment should use Iglim MV 2 mg/500 mg/0.2 mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation at a low dose is typical; however, this medication is unsuitable for individuals with severe hepatic dysfunction.
What if you forget to take Iglim MV 2 mg/500 mg/0.2 mg Tablet :
Should you forget to take your Iglim MV 2 mg/500 mg/0.2 mg Tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Iglim MV 2 mg/500 mg/0.2 mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently